Cargando…

Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis

BACKGROUND: The effect of the anatomic location of HCC on the prognosis of patients after hepatectomy is currently unclear. METHODS: Patients who underwent hepatectomy were retrospectively enrolled and divided into the right tumour resection group (R group) and the left tumour resection group (L gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lian, Xu, Liangliang, Zhou, Siqi, Wang, Peng, Zhang, Ming, Li, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935716/
https://www.ncbi.nlm.nih.gov/pubmed/35313888
http://dx.doi.org/10.1186/s12893-022-01564-5
_version_ 1784672087355424768
author Li, Lian
Xu, Liangliang
Zhou, Siqi
Wang, Peng
Zhang, Ming
Li, Bo
author_facet Li, Lian
Xu, Liangliang
Zhou, Siqi
Wang, Peng
Zhang, Ming
Li, Bo
author_sort Li, Lian
collection PubMed
description BACKGROUND: The effect of the anatomic location of HCC on the prognosis of patients after hepatectomy is currently unclear. METHODS: Patients who underwent hepatectomy were retrospectively enrolled and divided into the right tumour resection group (R group) and the left tumour resection group (L group) according to the tumour anatomic location. To avoid bias, 1:2 propensity score matching (PSM) analysis was used. Based on the survival data, disease-free survival (DFS) and overall survival (OS) were evaluated by the Kaplan–Meier method, and long-term survival analysis was performed. Cox proportional hazards regression was used to analyse the risk factors associated with postoperative prognosis. RESULTS: A total of 700 patients were enrolled in our study. After 1:2 PSM, 354 and 177 patients were enrolled in the R group and the L group, respectively, with comparable baseline characteristics. Survival analysis showed that patients in the L group had a significantly higher recurrence rate than patients in the R group (P = 0.036), but there was no significant difference in the survival rate (P = 0.99). Long-term survival analysis showed that the survival rate of the L group was lower than that of the R group (P < 0.01). Multivariate analysis showed that tumour location in the left liver was an independent risk factor for tumour recurrence (hazard ratio, 1.263; 95% CI, 1.005–1.587) and long-term survival (hazard ratio, 3.232; 95% CI, 1.284–8.134). CONCLUSION: For HCC patients, the recurrence rate and long-term survival rate of left liver tumours were significantly higher than those of right liver tumours, indicating that the anatomical location of the tumour has a significant effect on the survival of HCC patients. Trial registration Chinese Clinical Trial Registry, ChiCTR2100052407. Registered 25 October 2021, http://www.chictr.org.cn/showproj.aspx?proj=135500.
format Online
Article
Text
id pubmed-8935716
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89357162022-03-23 Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis Li, Lian Xu, Liangliang Zhou, Siqi Wang, Peng Zhang, Ming Li, Bo BMC Surg Research BACKGROUND: The effect of the anatomic location of HCC on the prognosis of patients after hepatectomy is currently unclear. METHODS: Patients who underwent hepatectomy were retrospectively enrolled and divided into the right tumour resection group (R group) and the left tumour resection group (L group) according to the tumour anatomic location. To avoid bias, 1:2 propensity score matching (PSM) analysis was used. Based on the survival data, disease-free survival (DFS) and overall survival (OS) were evaluated by the Kaplan–Meier method, and long-term survival analysis was performed. Cox proportional hazards regression was used to analyse the risk factors associated with postoperative prognosis. RESULTS: A total of 700 patients were enrolled in our study. After 1:2 PSM, 354 and 177 patients were enrolled in the R group and the L group, respectively, with comparable baseline characteristics. Survival analysis showed that patients in the L group had a significantly higher recurrence rate than patients in the R group (P = 0.036), but there was no significant difference in the survival rate (P = 0.99). Long-term survival analysis showed that the survival rate of the L group was lower than that of the R group (P < 0.01). Multivariate analysis showed that tumour location in the left liver was an independent risk factor for tumour recurrence (hazard ratio, 1.263; 95% CI, 1.005–1.587) and long-term survival (hazard ratio, 3.232; 95% CI, 1.284–8.134). CONCLUSION: For HCC patients, the recurrence rate and long-term survival rate of left liver tumours were significantly higher than those of right liver tumours, indicating that the anatomical location of the tumour has a significant effect on the survival of HCC patients. Trial registration Chinese Clinical Trial Registry, ChiCTR2100052407. Registered 25 October 2021, http://www.chictr.org.cn/showproj.aspx?proj=135500. BioMed Central 2022-03-21 /pmc/articles/PMC8935716/ /pubmed/35313888 http://dx.doi.org/10.1186/s12893-022-01564-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Lian
Xu, Liangliang
Zhou, Siqi
Wang, Peng
Zhang, Ming
Li, Bo
Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis
title Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis
title_full Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis
title_fullStr Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis
title_full_unstemmed Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis
title_short Tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis
title_sort tumour site is a risk factor for hepatocellular carcinoma after hepatectomy: a 1:2 propensity score matching analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935716/
https://www.ncbi.nlm.nih.gov/pubmed/35313888
http://dx.doi.org/10.1186/s12893-022-01564-5
work_keys_str_mv AT lilian tumoursiteisariskfactorforhepatocellularcarcinomaafterhepatectomya12propensityscorematchinganalysis
AT xuliangliang tumoursiteisariskfactorforhepatocellularcarcinomaafterhepatectomya12propensityscorematchinganalysis
AT zhousiqi tumoursiteisariskfactorforhepatocellularcarcinomaafterhepatectomya12propensityscorematchinganalysis
AT wangpeng tumoursiteisariskfactorforhepatocellularcarcinomaafterhepatectomya12propensityscorematchinganalysis
AT zhangming tumoursiteisariskfactorforhepatocellularcarcinomaafterhepatectomya12propensityscorematchinganalysis
AT libo tumoursiteisariskfactorforhepatocellularcarcinomaafterhepatectomya12propensityscorematchinganalysis